US 7285532
Therapeutic method for treating bone formation diseases
granted A61KA61K38/00A61K39/00
Quick answer
US patent 7285532 (Therapeutic method for treating bone formation diseases) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/00, A61K39/00